Snuggle Hot Water bottles with cover (assorted) (updated)
The hot water bottles do not have the required safety warning permanently marked on them according to the mandatory standard for hot water bottles.
227 archived Australian notices, each linked to its official Product Safety Australia source. The page updates automatically when new notices arrive.
Showing notices 1–48 of 227.
The hot water bottles do not have the required safety warning permanently marked on them according to the mandatory standard for hot water bottles.
The products were sold without the warning information that is required for products containing button/coin batteries.
The mesh plate the flask sits on may contain asbestos. There is a risk of exposure to asbestos fibres when using this product.
The corners of some mats may lift up or curl, creating a trip hazard.
The product does not comply with the mandatory safety standard for products containing button/coin batteries . The packaging does not display the required warning label and does not display treatment advice in case of ingestion.
These products were supplied within Australia for therapeutic use, without being registered on the Australian Register of Therapeutic Goods (ARTG). These products have not been assessed as required, so their safety and efficacy are unknown. For example, Glow Maxx is noted on the label to contain 1000 micrograms (mcg) of Vitamin D per capsule (per day). Medicines in Australia require a prescription if they contain more than 25 micrograms of Vitamin D per recommended daily dose. 1000 micrograms per day is 40 times this amount and, after prolonged use, could result in toxic effects such as vomiting and diarrhoea.
These two products contain fennel as an active ingredient. The label on the bottle does not include mandatory wording required for pregnancy and children warning statements.
ComforCleanse contains an extract from Foeniculum vulgare (fennel). The label on the bottle does not include mandatory wording required for pregnancy and children warning statements.
Insulin leakage has occurred with the Accu-Chek Solo Cannula Assembly and Pump Holder. If the insulin leakage is not immediately noticed when using the Accu-Chek Solo system this could potentially lead to an under-delivery of insulin.
The power cord supplied in affected products does not comply with requirements in the Medical electrical equipment standard IEC60601-1.
The nut securing the frame’s cross brace in place may become loose over time, leading to the frame becoming unstable.
Detox + Debloat tablets contains an extract from Foeniculum vulgare (fennel seeds). The bottle does not have required pregnancy and children warning statements on the label.
Some 100g jars of Vicks VapoRub Xtra Strong in batch number 222605 have been incorrectly labelled as Vicks VapoRub.
The affected masks contain magnets which can potentially affect the functioning of implanted medical devices such as metal splinters in the eyes, brain shunts, aneurysm clips, pacemakers, implantable cardioverter defibrillators, defibrillators, VP shunts, and neurostimulators used in and around the neck or any implanted medical device impacted by magnetic fields. Philips Respironics is updating the existing contraindications and warnings on the Instructions For Use (IFU) to strengthen the current labelling and warnings related to magnets.
The instructional leaflet enclosed with the bottle contains diagrams showing how to use the product safely. One diagram is shown out of order and with no context, this may result in users incorrectly removing the dosing component from the bottle and pouring the powder out unrestricted.
The product's battery pack may swell, leak fluid or overheat and could catch on fire.
The tablet may not dissolve properly and this can result in incomplete release of the medicine.
Certain devices were built with motor assemblies that may contain non-conforming plastic material.
The recall is due to microbial ( Aspergillus tubingensis, Sordaria humana, Penicillium paneum and Paenibacillus glucanolyticu s) contamination.
The gold battery cap contact may fall off when the user is charging the battery. If the contact falls off, the 'Insert battery' alarm will not clear automatically when the user inserts a new AA battery as the circuit is not complete. This will result in the alarm escalating to a siren and then the pump will shut down and will not power up.
The insulin pump may experience software issues which may disrupt insulin delivery.
Reports of allergic reaction.
The seals on some of the product may become damaged or broken when handled. If the seal on the pouch opens before use, the dressing may lose its microbiological barrier and become non-sterile.
The backrest of outdoor rollators may break. The current version of the products Information For Use does not contain any warning to ensure correct use and maintenance of the product.
The product contains the undeclared substances phenolphthalein and sibutramine. The products were supplied without an active Australian Registry for Therapeutic Goods (ARTG) registration.
The recall is due to potential microbial contamination ( Cronobacter and Salmonella ).
Batch N0121301 of the hard capsule shells contain ethylene oxide (ETO).
The instructions inside the product has incorrect labelling: The customer medicine information has incomplete description of the active ingredient and its appearance. The pack insert incorrectly states: ‘Do not keep the NovoMix® 30 Penfill® that you are using, or that you are carrying as a spare, with you. The storage conditions are correctly stated on the product carton. The correct statement reads: ‘You can carry the NovoMix® 30 Penfill® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’
The storage instructions inside the product has incorrect labelling. The pack insert incorrectly states: ‘Do not keep the NovoRapid® FlexPen® that you are using, or that you are carrying as a spare, with you. The storage conditions are correctly stated on the product carton. The correct statement reads: ‘You can carry the NovoRapid® FlexPen® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’
The storage instructions inside the product has incorrect labelling. The pack insert incorrectly states: ‘Do not keep the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. The storage conditions are correctly stated on the product carton. The correct statement reads: ‘You can carry the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’
The Medtronic WR9220 and WR9200 Rechargers may become unresponsive when: the product is fully depleted; and placed on the dock; and quickly removed within 20 seconds, interrupting the initialisation routine. When the Wireless Recharger becomes unresponsive, the Wireless Recharger: will not respond to a button press cannot pair with the recharger app the recharger battery indicator will flash continuously when placed on the battery dock.
The sound abatement washer may break down resulting in metal on metal wear inside the Pressure Equalisation (PE) valve. This may lead to high temperatures and overheating, separation of the shroud from the device, and loud noise, and can result in a fire that will shut down the device.
The Lidocaine Hydrochloride topical solution can become stronger than intended.
The level of tetrahydrocannabinol (THC) in this batch is too low and outside of the labelled concentration.
An unauthorised individual in close proximity to an insulin pump user could potentially copy the wireless RF signals from the user’s remote controller and play those back later to deliver an additional bolus of insulin to the pump user or to suspend insulin delivery.
When multiple devices are used on one account and certain changes in setting are made, a software bug on an Android device may cause the app to recommend an incorrect insulin reading.
A fault in the programming of the LX9 pumps, may cause users to experience higher pressure in the garments than set on the device.
The implant may stop working due to a complete loss of communication between the implant and the sound processor.
If the pump retainer ring breaks, the reservoir may become loose and may not lock into the pump.
The Instructions For Use leaflet was not supplied with the product. The Instructions For Use provide important safety information for the user.
Two software issues have been identified that relate to a pressure increase in the ventilators. 1. Infant/Pediatric External Flow Sensor (EFS) Calibration Pressure increase. An increase in the expiratory pressure (EPAP/PEEP) can occur when the paediatric/infant External Flow Sensor is used with an Active Flow or Dual Limb circuit and a manual circuit calibration is performed. 2. Pressure Drift (Continuous Usage). When a Trilogy Evo or Trilogy Evo O2 model is used continuously without any interruption to therapy, the baseline pressure may increase or decrease.
Certain M5072A Infant/Child SMART Pads Cartridges (LOT Number Y111220-01) contain an incorrect image underneath the PULL handle on the protective cover that shows the pad placement for an adult’s chest (Figure 2). The image on the protective cover should show a drawing of pad placement for a child’s chest and back (Figure 1). The image is correct on the outer pouch that contains the infant/child pads cartridge (Figure 3).
The affected product batch 18039 exceeds the specification for total yeast and mould counts (TYMC).
The product's patient information leaflet and patient implant card have been left out when the products were supplied. The implantation card and patient information sheet provide traceability of the products and important safety information for the patient.
The packaging of the adhesive wound dressings is not sealed together completely, leaving partial or fully open seals. The product may become non-sterile if the seal is open.
Bottles in affected batch number 754020 are mislabelled. These bottles may contain Para Tone multi-vitamin tablets instead of Sym Balance multi-vitamin tablets.
The products were supplied in the Australian market without an active Australian Registry for Therapeutic Goods (ARTG) registration and which were also labelled to contain Azadirachta indica ‘Neem’, Melia azdarach, or Acorus calumus.
The backrest may detach from the chair.